Abstract: An electrolyte additive for a rechargeable lithium battery includes a polymer obtained by polymerizing first compound represented by Chemical Formula 1, Chemical Formula 2, or Chemical Formula 3 as a monomer; and second compound represented by Chemical Formula 4.

Abstract: The present specification provides: a method for generating a virtual organoid having various shapes and features; and a virtual organoid imaging method capable of obtaining the same effect as image data obtained from an actual organoid. The virtual organoid generation method according to the present specification may generate data relating to an organoid structure in a virtual space so as to apply the feature of an actual organoid. The imaging method using the virtual organoid according to the present specification enables generation of image data which can obtain the same effect as capturing an image of an actual organoid.

Abstract: A novel senotherapy peptide and a method for senotherapy are disclosed. The method for sentherapy includes administering an effective amount thereof to a subject in need thereof. The novel senotherapy peptide suppresses the interaction between p53 and FOXO4 in the nucleus due to a better binding force with p53 than FOXO4, thereby allowing p53 to be released out of the nucleus and move to mitochondria to induce apoptosis of senescent cells and selectively induce the apoptosis of senescent cells in the skin cells.

Abstract: A method for generating a virtual organoid having various shapes and characteristics; and a virtual organoid photographing method which can achieve the same effect as that of image data obtained by photographing a real organoid. The method for generating a virtual organoid according to the present specification may generate data about an organoid structure in a virtual space to reflect the characteristics of a real organoid. The photographing method using a virtual organoid according to the present specification may generate image data which can achieve the same effect as that achieved when photographing a real organoid.

Abstract: A system and a method which are capable of: collecting packets on a network so as to generate a flow and a session in stages; performing a traffic inspection by using only a small number of packets on the basis of the generated information; and searching packets at a high speed while reducing storage capacity of a packet.

Abstract: The present invention relates to a stabilized external preparation comprising thymosin beta 4 (T?4) as an active ingredient. More specifically, the present invention relates to a therapeutically effective external preparation with improved stability and biological activity of T?4. The preparation according to the present invention provides T?4 in a stable state by maintaining the biological activity of T?4 and minimizing the generation of T?4 sulfoxide through oxidization reactions and multimers through aggregation.

Abstract: A system and a method which are capable of: collecting packets on a network so as to generate a flow and a session in stages; performing a traffic inspection by using only a small number of packets on the basis of the generated information; and searching packets at a high speed while reducing storage capacity of a packet.

Abstract: A network security system performing adaptive rule-set setting, and a method therefor. The network security method includes: a step of performing a trespass detection or prevention process to detect a security threat according to a preset applicable security rule-set among a plurality of packets that a network security system receives from a network, or to enable only a permitted packet to pass, and a packet storage process to selectively store at least a part of the plurality of packets; and a step in which the network security system changes the applicable security rule-set to be applied to the trespass detection or prevention process from a first security so rule-set to a second security rule-set on the basis of the stored packets stored through the packet storage process.

Abstract: The present invention relates to a method for manufacturing an ophthalmic preparation comprising thymosin ?4. According to the inventive method, the manufacture of an ophthalmic preparation comprising thymosin ?4 is carried out in the presence of an inert gas, thus the contact of thymosin ?4 with oxygen is blocked and the oxidation of thymosin ?4 can be prevented and the pharmacological activity of thymosin ?4 maintains for long-term period. Therefore, the ophthalmic preparation prepared by the inventive method can maintain the pharmacological activity of thymosin ?4 in a stable state for a long time.

Abstract: Provided is a semi-automatic air gun that is capable of allowing a hammer to be loaded at the same time when pellets are fired, with a portion of the compressed air discharged from a compressed air tank so as to fire the bullets, so that the hammer and a pellet loading unit move horizontally together to permit the loading and firing of the pellets to be carried out in a semi-automatic manner, thereby making it simple in configuration and obtaining a remarkably excellent compressed air use efficiency.

Abstract: The present invention relates to a therapeutic agent for ophthalmic disease containing thymosin beta 4. The present invention is more effective in reducing xerophthalmia than an ophthalmic solution containing cyclosporine A, is less irritant to eyes than conventional ophthalmic solutions and is physiochemically safe.

Abstract: Provided is a semi-automatic air gun that is capable of allowing a hammer to be loaded at the same time when pellets are fired, with a portion of the compressed air discharged from a compressed air tank so as to fire the bullets, so that the hammer and a pellet loading unit move horizontally together to permit the loading and firing of the pellets to be carried out in a semi-automatic manner, thereby making it simple in configuration and obtaining a remarkably excellent compressed air use efficiency.

Abstract: The present invention relates to a stabilized external preparation comprising thymosin beta 4 (T?4) as an active ingredient. More specifically, the present invention relates to a therapeutically effective external preparation with improved stability and biological activity of T?4. The preparation according to the present invention provides T?4 in a stable state by maintaining the biological activity of T?4 and minimizing the generation of T?4 sulfoxide through oxidization reactions and multimers through aggregation.

Abstract: The present invention relates to a method for manufacturing an ophthalmic preparation comprising thymosin ?4. According to the inventive method, the manufacture of an ophthalmic preparation comprising thymosin ?4 is carried out in the presence of an inert gas, thus the contact of thymosin ?4 with oxygen is blocked and the oxidation of thymosin ?4 can be prevented and the pharmacological activity of thymosin ?4 maintains for long-term period. Therefore, the ophthalmic preparation prepared by the inventive method can maintain the pharmacological activity of thymosin ?4 in a stable state for a long time.

Abstract: A semiconductor device includes a substrate, a two-dimensional (2D) material layer formed on the substrate and having a first region and a second region adjacent to the first region, and a source electrode and a drain electrode provided to be respectively in contact with the first region and the second region of the 2D material layer, the second region of the 2D material layer including an oxygen adsorption material layer in which oxygen is adsorbed on a surface of the second region.

Abstract: The present invention relates to a therapeutic agent for ophthalmic disease containing thymosin beta 4. The present invention is more effective in reducing xerophthalmia than an ophthalmic solution containing cyclosporine A, is less irritant to eyes than conventional ophthalmic solutions and is physiochemically safe.

Abstract: A demand response apparatus receives from a supply resource utilizing apparatus a signal indicating whether power supply from the demand response apparatus to the supply resource utilizing apparatus is possible, estimates a first power usage of the demand response apparatus for a first time interval, changes an operation of the demand response apparatus, estimates a second power usage for a second time interval after the changing of the operation of the demand response apparatus, calculates supply power available to the supply resource utilizing apparatus based on the estimated first power usage and the estimated second power usage, and transmits information about the available supply power to the supply resource utilizing apparatus.

Abstract: The present disclosure relates to a composition for promoting immune activity including a protein selected from the group consisting of dimeric proinsulin, C-peptide partially deleted mutant of dimeric proinsulin, and C-peptide partially deleted mutant of monomeric proinsulin as an effective component and a composition for immunosuppression including C-peptide site of proinsulin as an effective component, and the dimeric proinsulin, the C-peptide partially deleted mutant of dimeric proinsulin, and the C-peptide partially deleted mutant of monomeric proinsulin can be applied as immune enhancers to diabetic patients.

Abstract: A semiconductor device includes a substrate, a two-dimensional (2D) material layer formed on the substrate and having a first region and a second region adjacent to the first region, and a source electrode and a drain electrode provided to be respectively in contact with the first region and the second region of the 2D material layer, the second region of the 2D material layer including an oxygen adsorption material layer in which oxygen is adsorbed on a surface of the second region.

Abstract: An apparatus and method for collecting power from distributed power supply resources are provided. The method includes transmitting a signal for inquiring whether supply of demand-side power supply resources is possible to a providing side that provides demand-side power supply resources, selecting demand-side power supply resources to be utilized, based on power supply resource-related information for each of available demand-side power supply resources, which is received from the providing side, and notifying the selection results to the selected demand-side power supply resources.